Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Announced details
マニートラベクロトミーフック
Applicable field (uses covered by this announcement)
眼科緑内障手術
Launch date2026年1月26日より全国での販売を開始（予定ではなく発表時点での開始日）
Registration number and expiry date
医療機器認証番号：306ABBZX00026000
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | マニートラベクロトミーフック |
| Launch date | 2026年1月26日より全国での販売を開始（予定ではなく発表時点での開始日） |
| Applicable area | 眼科緑内障手術 |
| Registration number and expiry date | 医療機器認証番号：306ABBZX00026000 |
Items this document does not state (14)
CounterpartyCounterparty overviewRelationship with the CompanyContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.緑内障手術における精密な切開をサポートし、術者の操作性および安全性の向上に寄与するため。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.